Community news|31/03/16

The use of performance-enhancing drugs in the workplace

Home > The news of EUROGIP and occupational risks in Europe > The use of performance-enhancing drugs in the workplace

An article published on the OSHwiki platform – which operates on the principle of the Wikipedia, but with regard to occupational safety and health – sheds light on the use of performance-enhancing drugs in the workplace. This practice is likely to become even more prevalent in future.

According to the authors, it is hard to measure this phenomenon, because these drugs are usually bought over the internet and they are not taken as a result of medical prescription. However, there is evidence of abuse, which has become almost standard, in certain activities and jobs. Those concerned are, for example, long-distance road hauliers, shift workers in healthcare and emergency responder services, the military forces and certain workers subjected to high pressure, such as city traders and lawyers, or to strong competition, such as businessmen.

The article discusses the question of the effects of drug consumption on work and workers, and the implications for occupational safety and health.

It forms part of a series focusing on the future of work. It was produced by EU-OSHA, in cooperation with Dr Karen Dale and Professor Brian Bloomfield of the University of Lancaster, after a seminar with EU-OSHA focal points in the Member States, and the European Commission.

Read the article

Discover other news

Community news

08/10/25

Healthy Workplaces Good Practice Awards 2025

This competition recognizes innovative and sustainable approaches to occupational risk prevention across Europe. This year, the European Agency for Safety and Health at Work (EU-OSHA) is awarding prizes for the introduction of digital systems in the workplace.

News

23/09/25

PSR prevention: next EUROGIP report announced in Marseille

At the end of September, EUROGIP was invited by Carsat Sud-Est to present an overview of mental health in the workplace abroad. On this occasion, Anna Piazza, researcher at EUROGIP, revealed some details of her upcoming report on the prevention of psychosocial risks (PSR) in the workplace in Europe and internationally.